DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20162908

Detection of virulence determinants and its association with drug resistance in clinical isolates of Pseudomonas aeruginosa

Pramodhini S., Umadevi S., Seetha K. S.

Abstract


Background: Pseudomonas aeruginosa is most commonly noted significant nosocomial pathogen, because of its distribution, of multi drug resistance and expression of various virulence factors. This study was aimed to detect various resistance mechanism and virulence factors of Pseudomonas aeruginosa and to determine the significant association between them.

Methods: A total of 203 clinical isolates of Pseudomonas aeruginosa were included in this study. All isolates were detected for various virulence factors like Phospholipase, Hemolysin, Gelatinase and DNAse. Screening of β-lactamase like extended spectrum beta-lactamase (ESBL), AmpC beta-lactamase and Metallo β-lactamase (MBL) of Pseudomonas aeruginosa were also done.

Results: Of total 203 isolates of Pseudomonas aeruginosa studied, 103 were from pus, 50 each from urine and respiratory samples. Virulence factors distribution of Pseudomonas aeruginosa showed 80.3% ,70% , 71.4% , 44.8% and 34% were positive for hemolysin, phospholipase, gelatinase, DNAse and biofilm production respectively. Study on prevalence of various β-lactamase in Pseudomonas aeruginosa isolated showed 25.6%, 24.1% and 10.3% were ESBL, MBL and AmpC producers respectively.

Conclusions: This study suggests that production of virulence factors may not be significantly associated with antibiotic resistance. However, expression of certain virulence factors, most notably hemolysin and DNAse activity were significantly associated with β-lactamase production. Hence forth, future trends in clinical microbiology laboratories should focus on development of tests for the rapid detection of the most important virulence markers in addition to identification of pathogens and susceptibility pattern.


Keywords


Pseudomonas aeruginosa, Virulence factors, Extended spectrum beta-lactamase, AmpC beta-lactamase, Metallo β-lactamase

Full Text:

PDF

References


Koneman EW, Allen SD, Janda WM, Schrenkenberger PC, Winn WC. Colour Atlas and Textbook of Diagnostic Microbiology, 5th ed. Lippincott Williams & Wilkins, PA. 1997.

Pavlov D, De Wet CME, Grabow WOK, Ehlers MM. Potentially pathogenic features of heterotrophic plate count bacteria isolated from treated and untreated drinking water. Int J Food Microbiol. 2004;92:275-87.

Mittal R, Khandwaha RK, Gupta V, Mittal PK, Harjai K. Phenotypic characters of urinary isolates of Pseudomonas aeruginosa & their association with mouse renal colonization. Indian J Med Res. 2006;123:67-72.

Mac Faddin JF. Biochemical Tests for Identification of Medical Bacteria, 2nd edn. Williams and Wilkins, Baltimor. 1980.

Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A (eds). Mackie and McCartney Practical Medical Microbiology. 14th edn. Edinborough: Churchill Livingstone. 1996:131-52.

Prasad SV, Ballal M, Shivananda PG. Slime production a virulence marker in Pseudomonas aeruginosa strains isolated from clinical and environmental specimens: A comparative study of two methods. Indian J Pathol Microbiol. 2009;52:191-3.

Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement ed. CLSI document M100-S20. CLSI: Wayne. PA. 2013.

Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem–EDTA disk method for differentiation of metallo β lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40:3798-801.

Upadhyay S, Sen MR, Bhattacharjee A. Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase enzyme. J Infect Dev Ctries. 2010;4(4):239-42.

Morrison AJ, Wenzel RP: Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis. 1984;6:S627-S642.

Pollack M: Pseudomonas aeruginosa. In Principles and Practice of infectious diseases Edited by: Mandell GL, Bennett JE, Dolin R. New York: Churchill Livingstone. 1995:1980-2003.

Van Delden C, Iglewski BH. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis. 1998;4:551-60.

Khalil MAEF, Sonbol FI, Mohamed AFB, Sameh SA. Comparative study of virulence factors among ESβL-producing and nonproducing Pseudomonas aeruginosa clinical isolates. Turk J Med Sci. 2015;45:60-9.

Mohammad HH. Phenotypic Investigation for Virulence factors of Pyocine producing Pseudomonas aeruginosa Isolated from Burn Wounds, Iraq. International Journal of Scientific & Engineering Research. 2013;4(7):2114-21.

Finlayson EA, Brown PD. Comparison of antibiotic resistance and virulence factors in pigmented and non-pigmented Pseudomonas aeruginosa. West Indian Med J. 2011;60:24-32.

Oliveira A, Maria de Lourdes RS Cunha. Comparison of methods for the detection of biofilm production in coagulase-negative staphylococci. BMC Research Notes. 2010;3:260.

Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A. Detection of biofilm formation among the clinical isolates of staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol. 2006;24(1):25-9.

Kaur DC, Wankhede SV. A study of Biofilm formation &Metallo-β-Lactamases in Pseudomonas aeruginosa in a tertiary care hospital. International Journal of Scientific and Research Publications. 2013;3(10):1-7.

Zafer MM, Al-Agamy MH, El-Mahallawy HA, Amin MA, El-Din Ashour MS. Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes among Pseudomonas aeruginosa Strains Isolated from Cancer Patients. Bio Med Research International. 2014.

Chaudhari VL, Gunjal SS, Mehta M. Antibiotic resistance patterns of pseudomonas aeruginosa in a tertiary care hospital in Central India. Int J Med Sci Public Health. 2013;2:386-9.

Amutha R, Padmakrishnan, Murugan T, Renugadevi MP. Studies on multidrug resistant Pseudomonas aeruginosa from pediatric population with special reference to extended spectrum beta lactamase. Indian Journal of Science and Technology. 2009;2(11):11-3.

Joseph NM, Devi S, Shashikala P, Kanungo R. Changing Trend in the Antibiotic Resistance Pattern of Pseudomonas aeruginosa Isolated from Wound Swabs of Out-Patients and in-Patients of a Tertiary Care Hospital. Journal of Clinical and Diagnostic Research. 2013;7(10):2170-2.

Senthamarai S, Reddy SKA, Sivasankari S, Anitha C, Somasunder V, Kumudhavathi MS, et al. Resistance Pattern of Pseudomonas aeruginosa in a Tertiary Care Hospital of Kanchipuram, Tamilnadu, India. Journal of Clinical and Diagnostic Research. 2014;8(5):30-2.

Manchanda V, Singh NP. Occurrence and detection of AmpC b-lactamases among Gram negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother. 2008;51:415-8.

Aggarwal R, Chaudhary U, Bala K. Detection of extended‑spectrum beta‑lactamase in Pseudomonas aeruginosa. Indian J Pathol Microbiol. 2008;51:222‑4.

Umadevi S, Joseph NM, Kumari K, Easow JM, Kumar S, Stephen S, et al. Detection of Extended Spectrum Beta Lactamases, Ampc Beta Lactamases and Metallobetalactamases In Clinical Isolates Of Ceftazidime Resistant Pseudomonas aeruginosa. Brazilian Journal of Microbiology. 2011;42:1284-8.

Varaiya A, Kulkarni N, Kulkarni M, Bhalekar P, Dogra J. Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patient. Indian J Med Res. 2008;127:398-402.

Shahid S, Malik A, Agrawal M, Singhal S. Phenotypic detection of extended spectrum and AmpC β-lactamases by a new spot inoculation method and modied three dimensional extract test: Comparison with the conventional three-dimensional extract test. J Antimicrob Chemother. 2004;54:684-7.

Shashikala, Kanungo R, Srinivasan S, Devi S. Emerging resistance to carbapenem in hospital acquired Pseudomonas infection: A cause of concern. Indian J Pharmacol. 2006;38:287-8.

Mansouri S, Norouzi F, Moradi M, Nakhaae N. Comparison of virulence factors among clinical isolates of Pseudomonas aeruginosa producing and non-producing extended spectrum beta-lactamases. Curr Res Bacteriol. 2011;4:85-93.

Bradbury RS, Roddam LF, Merritt A, Reid DW, Champion AC. Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa. J. Med. Microbiol. 2010;59:881-90.

Deptula A, Gospodarek E. Reduced expression of virulence factors in multidrug resistant Pseudomonas aeruginosa strains. Arch. Microbiol. 2010;192:79-84.

Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World? Alejandro Beceiro, María Tomás, Germán Bou. Clin. Microbiol. Rev. 2013;26(2):185.